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Abstract 
This article reviews and describes trends and differences in prevalence of type 2 diabetes mellitus of 
Chinese populations in Mainland China, Hong Kong and Taiwan based on literatures published in the 
MEDLINE Advanced database (January 1966–October 2005) in both Chinese and English languages. 
Chinese populations in Hong Kong and Taiwan have significant higher prevalence rates of diabetes 
than their Mainland counterparts, with odds ratios 1.5 (95% confidence intervals: 1.4, 1.7) and 2.0 
(95% confidence intervals: 1.8, 2.2), respectively in 1995–2003 adjusted for age and diagnostic criteria. 
Using stratified diagnostic criteria; the odds ratios in Hong Kong and Taiwan were consistently higher 
than Mainland China for the periods of 1985–1994 and 1995–2003. A large proportion, i.e. 68.6% 
(95% confidence intervals: 67.4%, 69.7%) of diabetic patients remains undiagnosed in Mainland China 
as compared to 52.6% (95% confidence intervals: 49.8%, 55.5%) undiagnosed in Hong Kong and 
Taiwan. The prevalence rates of diabetes and impaired glucose tolerance of the Chinese populations 
rise in older age groups. In tandem with economic development and change toward lifestyle that is lack 
of physical activity and rich in high-fat diet, prevalence of diabetes of the Chinese populations are on 
the rise. If the undiagnosed individuals left uncontrolled, they are subject to higher risks of developing 
diabetes and its complications. These will increase the burdens of diabetes medically and financially.  
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1. Introduction 
 
Along with India, China is one of the countries with the largest number of people suffering 
from diabetes mellitus [1]. The number of diabetic patients in China is estimated to increase 
from 20.8 million in 2000 to 42.3 million in 2030 [2]. In the light of economic advancement, 
urbanisation and change of lifestyle take place in Mainland China. On the other hand, Chinese 
people who live in urbanised location outside Mainland China such as Hong Kong experience 
change in environment and lifestyle which can affect the development of diabetes [3]. 
Chinese people in Hong Kong and Taiwan are genetically comparable to their Mainland 
counterparts. The prevalence of diabetes of Chinese populations in Hong Kong and Taiwan 
may reflect the future upward trend in Mainland China. This article is specifically dedicated 
to describe the trends and differences in prevalence of diabetes of the Chinese populations in 
Mainland China, Hong Kong, and Taiwan. The prevalence rates reported in this review are 
for ‘type 2 diabetes mellitus’, which is referred to as ‘diabetes’ in this paper for simplicity. 
The data are useful for assessing the potential impact of the Chinese populations in their 
transition into future global burden of diabetes. 
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2. Method 
 
Searches were performed in MEDLINE Advanced database (January 1966–October 2005) 
with no limitation on language. The words ‘diabet*’, ‘Chinese’, ‘China’, ‘Hong Kong’, 
‘Taiwan’, and ‘prevalence*’ were explored in the searches. Referenced papers published in 
Chinese journals, which were not indexed in the MEDLINE database, were searched 
manually. Inclusion criteria were population-based study that reported methodology, 
diagnostic criteria, and Chinese's prevalence rate of diabetes. The summary of diagnostic 
criteria based on WHO [4], WHO [5] and ADA [6] is shown in Table 1. Other diagnostic 
criteria were indicated in the ‘criteria’ column and footnotes in Table 2. The following papers 
were excluded: studies that specifically deal with gestational diabetes or type 1 diabetes 
mellitus; commentary articles that did not provide primary data of studies; duplicated reports 
in which data were published in another cited paper. Prevalence of diabetes includes 
previously known and new (undiagnosed) diabetes. The undiagnosed individuals were those 
who did not know that they were suffering from diabetes until they were screened and 
diagnosed by using the relevant diagnostic criteria. The time variable was based on the year 
of the study completed. In papers that did not provide the year of study, the publication year 
was used instead. Odds ratios and their 95% confidence intervals were computed by using 
logistic regression adjusting for age of the participants (i.e. median of their age-range) and 
stratified by three diagnostic criteria. All analyses were performed by using Stata 8.0 [7].  
 
Table 1.  Diagnostic criteria of diabetes 
 WHO [4] WHO [5] ADA [6] 
DM FPG ≥ 7.8 or 2 h PG ≥ 11.1 FPG ≥ 7.0 or 2 h PG ≥ 11.1 FPG ≥ 7.0 
IGT FPG < 7.8 and 7.8 ≤ 2 h PG < 11.1 FPG < 7.0 and 7.8 ≤ 2 h PG < 11.1 7.8 ≤ 2 h PG < 11.1
All units are in mmol/l. Note: detailed elaboration of the diagnostic criteria are given in WHO [4], 
WHO [5] and ADA [6]. 
 
3. Results 
 
A total of 35 studies published in either Chinese or English languages were included in this 
review. Twenty-one studies were conducted in Mainland China [8], [9], [10], [11], [12], [13], 
[14], [15], [16], [17], [18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29] and 
[30] (1978–2003), four studies were conducted in Hong Kong [31], [32], [33] and [34] (1987–
1996), and 10 studies in Taiwan [35], [36], [37], [38], [39], [40], [41], [42], [43] and [44] 
(1985–2001). The details of the studies are shown in Table 2. 
 
Table 2. Studies of prevalence of diabetes in Mainland China, Hong Kong, 
and Taiwan  
Location Criteria Applied OGTT? Sampling methodology 
Mainland China 
 Shanghai, 1978 [8] 
N = 78298 Note 1 Yes 
Subjects were randomly selected according to 
the age, sex, and occupation distributions in 
Shanghai 
Diabetes Research and Clinical Practice (2006) 73 (2): 126-134.       doi:10.1016/j.diabres.2006.01.007 
 
Location Criteria Applied OGTT? Sampling methodology 
 14 Provinces, 1980 [9] and 
[11]  
N = 156119 
Note 2 Yes 
Subjects were randomly selected according to 
the age, sex, occupation, and ethnicity 
distributions in Mainland China 
 Beijing, 1980 [10] 
N = 21671 A Yes 
Subjects were randomly selected according to 
the age and sex distributions in Beijing 
 DaQing, 1986 [12] 
N = 110687 B Yes 
50% of the clinics in DaQing were randomly 
selected to screen subjects over a 6-month 
period 
 Beijing, 1993  
[13] and [14]  
N = 29938 
B Yes All employees over the age of 30 years working in 32 units of Shougang Corporation in Beijing 
 19 Provinces, 1994 [15]  
N = 213515 B Yes 
The selection of subjects depended on the 
willingness of local doctors to volunteer time 
and effort and the support by the local 
administrative office in 19 provinces in 
Mainland China 
 Shanghai, 1994 [16] 
N = 12509 B Yes 
Subjects were randomly selected from 11 
districts in Shanghai 
 Hubei, 1995 [17]  
N = 9446 B Yes 
Stratified random cluster sample of residents 
from urban and rural areas in Hubei province 
 Changsha, 1996 [18]  
N = 1369 B Yes 
Employees from 22 companies and enterprises 
in Changsha 
 Shenzhen, 1997 [19]  
N = 7842 B Yes 
Subjects were randomly selected proportional to 
the population density in each district and age 
distribution 
 Baotou, 1997 [20]  
N = 10867 B Yes 
Six work-units in Electric Power System in 
Baotou city were randomly selected. All the 
employees in the selected units were surveyed 
 11 Provinces, 1997 [21] 
N = 42751 B Yes 
Stratified cluster sample from 11 provinces in 
Mainland China 
 Beijing, 1997 [22]  
N = 1429 C Yes 
Population-based sample reported in DECODAa 
study 
 Shunyi, 1998 [22]  
N = 646 C Yes 
Population-based sample reported in DECODAa 
study 
 12 Provinces, 1998 [24] 
N = 27010 B Yes 
Stratified random sampling of residents over 40 
years old in 12 provinces in Mainland China 
 Shanghai, 2000 [25] C Yes Multiple-stage random sampling on residents aged 20 years and above and who had been 
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Location Criteria Applied OGTT? Sampling methodology 
N = 2771 living in Shanghai for more than 10 years 
 Baotou, 2000 [26]  
N = 20221 D Yes 
90% of the employees aged 20 years and above 
in Baotou Iron & Steel Company in Baotou city 
were screened 
 31 Provinces, 2001 [27] 
N = 15540 D No 
Four-stage stratified sampling to select 
nationally representative sample in 31 provinces 
in Mainland China 
 Qingdao, 2002 [29] 
N = 12436 C Yes 
Stratified random cluster sampling to select 
representative samples in rural and urban areas 
in Qingdao city 
 Chongqing, 2002 [28] 
N = 2810 C Yes 
Stratified random sampling of residents aged 20 
years and above in Chongqing 
 Hangzhou, 2003 [30] 
N = 4682 Note 3 Yes 
Multiple-stage stratified random sampling on 
residents aged 15 years and above in Hangzhou 
Outside Mainland China 
 Hong Kong, 1987 [31] 
N = 427 B Yes Cluster sampling of elderly (aged 60 and above)
 Hong Kong, 1993 [32] 
N = 1609 B Yes 
All employees from two work sites of a major 
public utility company and a regional hospital 
were invited to participate 
 Hong Kong, 1996 [34] 
N = 2664 B Yes 
Participants were selected randomly from the 
registry of telephone number 
 Hong Kong, 1996 [33] 
N = 1467 B Yes 
Members from seven community day-centers at 
various locations were invited to participate in a 
health-screening program 
 Taiwan, [Taipei] 1985 [35] 
N = 2206 A Yes 
Residents from 16 districts of Taipei were 
randomly sampled for the screening 
 Taiwan, [Pu Li] 1988 [36] 
N = 1152 B Yes 
Stratified cluster sampling based on the 
population density of the 31 neighborhoods in 
Pu Li 
 Taiwan, [Yang Ming]1989 
[37]  
N = 4713 
Note 4 No 
Residents from eight towns were surveyed by 
the Yang-Ming Crusade (National Yang-Ming 
Medical College) 
 Taiwan, [Ann-Lo] 1990 [38] 
N = 9087 Note 5 No 
One third of all the families in the Ann-Lo 
district were sampled randomly 
 Taiwan, [Kinmen] 1991 [39] 
N = 3236 B Yes 
According to household registration, subject 
≥30 years were invited to attend the screening 
test 
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Location Criteria Applied OGTT? Sampling methodology 
 Taiwan, [Hualian] 1995 [40] 
N = 580 B Yes 
Six villages were selected randomly from the 
Hualian county. Data from three Chinese (Han) 
villages were included in this review 
 Taiwan, [Penghu] 1996 [41] 
N = 1601 D No 
Stratified random sample proportional to the 
population density in six residential areas in 
Penghu 
 Taiwan, [Taipei] 1996 [42] 
N = 46 603 Note 6 No 
Individuals who attended a health-screening 
center for health examination of their own 
volition 
 Taiwan, [Tainan] 1996 [43] 
N = 1638 B Yes 
Stratified systematic cluster sample, i.e. the city 
was stratified into seven strata according to 
administrative districts in which every fifth 
household was selected 
 Taiwan, [Taipei] 2001 [44] 
N = 1293 D No 
Two-stage proportional stratified random 
cluster sample from each township from lists of 
all residents’ names 
 
N = total sample size. A: WHO, 1980, B: WHO [4], C: WHO [5], D: ADA [6]. Note 1: 
FPG > 130 mg/dl or 2 h post-prandial glucose > 160 mg/dl. Note 2: FPG > 130 mg/dl or 2 h post-
prandial glucose >200 mg/dl. Note 3: the version of WHO criteria was not stated. Note 4: fasting 
plasma glucose >140 mg/dl. Note 5: 2-hour post prandial blood glucose ≥200 mg/dl or subject has 
diabetic history and is receiving treatment. Note 6: 12 h fasting plasma glucose. FPG >126 mg/dl or use 
of anti-diabetic medication. 
a Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Asia. 
 
Each line in Fig. 1 represents the age-specific prevalence rates for one study of Chinese 
population. In the period of 1985–1994, Mainland Chinese's prevalence rates of diabetes were 
consistently lower than their counterparts in Hong Kong and Taiwan in the same age groups. 
In the period 1995–2003, the prevalence of diabetes in some studies in Mainland China 
remained low, but some studies were on par with or even higher than some of their 
counterparts in Hong Kong and Taiwan. The variations of the prevalence rates of diabetes in 
Mainland China were large (Fig. 1).  
After adjusting for age and diagnostic criteria, Chinese people in Hong Kong and 
Taiwan have a substantially higher prevalence of diabetes than their Mainland counterparts, 
with odds ratios 1.4 (95% confidence intervals: 1.1, 1.7) and 2.2 (95% confidence intervals: 
1.9, 2.5), respectively in 1985–1994. The corresponding odds ratios in 1995–2003 were 1.5 
(95% confidence intervals: 1.4, 1.7) [Hong Kong versus Mainland China] and 2.0 (95% 
confidence intervals: 1.8, 2.2) [Taiwan versus Mainland China]. To examine the trend over 
time in the prevalence of diabetes, we compared the prevalence rates of studies that applied 
WHO, 1985 criteria between two periods of 1985–1994 and 1995–2003 for Mainland China, 
and Hong Kong and Taiwan combined. The odds ratio in Mainland China was 1.33 (95% 
confidence interval: 1.28, 1.39) with the data from 1985 to 1994 as reference. The 
corresponding odds ratio in Hong Kong and Taiwan combined was 1.15 (95% confidence 
interval: 1.02, 1.32). 
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Fig. 1. Prevalence of diabetes of Chinese populations in Mainland China, Hong Kong and Taiwan. 
Note: Each line represents the age-specific prevalence rates for one study of Chinese population. 
 
We further stratified the analysis by diagnostic criteria to reduce the effect of change in 
diagnostic criteria on the variation of prevalence rates. As shown in Table 3, the odds ratios 
for Hong Kong and Taiwan versus Mainland China were significantly higher than the null 
effect in all strata with the data available.  
 
Table 3. Odds ratios stratified by diagnostic criteria and time, adjusted for age  
 Year WHO [4] ADA [6] 
  Odds ratio 95% CI Odds ratio 95% CI 
Hong Kong vs. Mainland China 
 1985–1994 1.40 1.15, 1.72 a a 
 1995–2003 1.56 1.40, 1.74 a a 
Taiwan vs. Mainland China 
 1985–1994 2.18 1.94, 2.45 a a 
 1995–2003 1.92 1.65, 2.23 2.1 1.81, 2.43
 
a No comparable studies published using the same diagnostic criteria during that period of time. 
 
The prevalence rates of diabetes and impaired glucose tolerance (IGT) rise in older age 
groups. The prevalence of IGT is higher than diabetes in younger age groups as reflected in 
the IGT/diabetes ratio, which generally declines as age increases (Fig. 2). 
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The prevalence rates of diabetes and impaired glucose tolerance (IGT) rise in older 
age groups. The prevalence of IGT is higher than diabetes in younger age groups as reflected 
in the IGT/diabetes ratio, which generally declines as age increases (Fig. 2). 
The percentage of undiagnosed diabetes is 68.6% (95% confidence interval: 67.4%, 
69.7%) in Mainland China as compared to 52.6% (95% confidence interval: 49.8%, 55.5%) in 
their counterparts in Hong Kong and Taiwan (Table 4). 
 
Table 4. Percentages of undiagnosed diabetes of the Chinese populations in 
Mainland China, Hong Kong and Taiwan  
Study Total diabetes Undiagnosed diabetes 
 N n Percentage 95% CI 
Mainland China 6157 4221 68.6 67.4, 69.7 
 19 Provinces, 1994 [15] 4868 3426 70.4 69.1, 71.7 
 Chongqing, 2002 [28] 368 195 53.0 47.7, 58.2 
 Qingdao, 2002 [29] 921 600 65.1 62.0, 68.2 
Hong Kong and Taiwan combined 1195 629 52.6 49.8, 55.5 
 Hong Kong, 1995 [34] 253 163 64.4 58.2, 70.3 
 Hong Kong, 1996 [33] 232 74 31.9 25.9, 38.3 
 Taiwan, [Taipei] 1985 [35] 133 75 56.4 47.5, 65.0 
 Taiwan, [Pu Li] 1988 [36] 143 66 46.2 37.7, 54.7 
 Taiwan, [Kinmen] 1991 [39] 211 146 69.2 62.5, 75.4 
 Taiwan, [Hualian] 1995 [40] 75 37 49.3 37.6, 61.1 
 Taiwan, [Tainan] 1996 [43] 148 68 45.9 37.7, 54.3 
 
4. Discussion 
 
In our review, we found that the prevalence rates of diabetes were consistently higher in Hong 
Kong and Taiwan than Mainland China regardless of diagnostic criteria for the periods of 
1985–1994 and 1995–2003. 
Chinese people in Hong Kong and Taiwan are generally living in an urbanised 
environment. Physical inactivity, diets high in fat and sodium and low in fruit and vegetables, 
and increase work-related stress are a few of the lifestyle factors associated with urbanisation 
[45]. In Hong Kong, with reference to two large-scale population-based studies, the 
prevalence of overweight (using BMI ≥ 25 kg/m2) increased from 28% to 38% in men, and 
from 28% to 34% in women in 1990 and 1995, respectively [46]. A prospective study on 
obese Hong Kong Chinese found that the obese people, after a mean follow-up of 2 years, had 
significantly higher rates of progression to diabetes (14.6% per year for people with 
BMI ≥ 28 kg/m2) than their non-obese counterparts (8.4% per year) [47]. 
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In Taiwan, a population-based nutritional survey revealed that 24.5% of the male and 
25.2% of the female adults in Taiwan were obese, and this prevalence was particularly high 
(men: 36.6%; women: 44.6%) among those aged 45–64 years [48]. A cross-sectional study in 
Taiwan (2002–2003) reported a significant upward trend of body mass index (BMI) of 
Taiwanese people. The obese Taiwanese are at increased risk of developing diabetes [48]. 
This finding was consistent with the reports from two large-scale studies (Nutrition and 
Health Survey in Taiwan 1993–1996, and Cardiovascular Disease Risk Factor Two-township 
Study 1994–1997) which stated that age-adjusted relative risk of diabetes were higher for 
people with increased BMI (BMI above 75th percentile) [49]. 
 
 
 
Fig. 2. Consolidated prevalence rates of diabetes and IGT, and IGT/diabetes ratio of the Chinese 
populations in Mainland China, Hong Kong and Taiwan based on studies that applied OGTT and 
WHO, 1985 criteria. Red bar: diabetes; blue bar: impaired glucose tolerance; 95% confidence intervals 
overlay on the bars. Red line: IGT/diabetes ratio. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of the article.) 
 
Within Mainland China, there is an upward trend in the prevalence of diabetes when the 
prevalence rates are compared between the time intervals (1985–1994 and 1995–2003) for the 
same age groups (Fig. 1 and Fig. 2). This upward trend can be addressed from aspects such as 
change of diagnostic criteria, urbanisation, and change of lifestyle (such as diet and physical 
activity) within Mainland China. With reference to the WHO, 1985 criteria, WHO, 1999 
criteria may over-estimate prevalence rates by 0.7–1.4%, and ADA, 1997 criteria may under-
estimate the rates by 2.1–2.4% [50] and [51] (Table 1). With omission of 2 h plasma glucose 
after a glucose challenge, fewer people will be diagnosed with diabetes. For an instance, a 
study in Hong Kong reported that the prevalence of diabetes (WHO, 1985 criteria) was 
reduced by half when ADA, 1997 criteria was applied by using fasting plasma glucose alone 
[52]. Hence, we calculated the odds ratio stratified by diagnostic criteria. Using the same 
diagnostic criteria and the same time period, the prevalence rates of diabetes were higher in 
Hong Kong and Taiwan (Table 3). There seems to be a catch up trend in the prevalence of 
diabetes in Mainland China. Using identical diagnostic criteria (WHO, 1985), we found that a 
33% increase in diabetes risk from 1985–1994 to 1995–2003 periods in Mainland China 
while only 15% in Hong Kong and Taiwan combined. 
The recent study of 31 provinces in Mainland China in 2000–2001 reported that the 
age-standardised prevalence of diabetes was 1.5-fold higher among urban residents (7.8%) as 
compared to rural residents (5.1%) (p < 0.001) [53]. Similarly, in 2002, a study on the 
prevalence of diabetes in urban and rural Chinese populations in Qingdao (Mainland China) 
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reported higher prevalence of diabetes in the urban versus rural areas, i.e. 6.9% versus 5.6% 
(p < 0.001) [29]. In a cosmopolitan city such as Shanghai in Mainland China, the lifestyle of 
the Chinese has changed markedly as a result of less physical activity and abundant food [54]. 
A study of dietary transition in China during the past 50 years based on data collected from 
the representative national surveys, i.e. China Health and Nutrition Survey (1989–1997) and 
China National Nutrition Survey (1982 and 1992) reported a trend that is shifting towards a 
high-fat, high-energy-density and low-fibre diet [55]. A national study in Mainland China 
reported that participation in moderate or vigorous leisure-time physical activity was low, 
being 7.9% and 28.9%, among urban and rural Chinese in Mainland China, respectively [56]. 
The age-standardised prevalence of overweight (BMI ≥ 25 kg/m2) was 26.9% (95% 
confidence intervals: 25.7–28.1%) in men and 31.1% (95% confidence intervals: 29.7–32.5%) 
in women [45]. This could have attributed to the upward trend of the prevalence of diabetes 
because overweight has been associated with increased risk of diabetes [57]. Another example 
is DaQing, which is an industrial city in Mainland China. A study comparing the prevalence 
rates in 1986 and 1994 showed that the standardised prevalence rates of diabetes were 1.04% 
and 3.51%, respectively, which showed a 3.4 times increase in an interval of 8 years [58]. 
The higher prevalence of diabetes in the older age groups of Chinese populations may 
raise concern in aging populations, as this will add greater burden to the healthcare cost. On 
the other hand, the prevalence rates of diabetes of the younger age groups (i.e. 20–29 and 30–
39 years) are relatively low, but the IGT/diabetes ratios are high in these groups (Fig. 2). 
There is higher risk for individuals with impaired glucose tolerance to progress to diabetes. 
The progression rates from IGT to diabetes are approximately 8.8% per year (95% confidence 
interval 6.3–11.3%) [59]. Hence, many of the current cohorts of younger populations will 
become diabetic patients if their IGT is undiagnosed and/or uncontrolled. 
Two out of three diabetic patients in Mainland China and half of the Chinese diabetic 
patients in Hong Kong and Taiwan remain undiagnosed. Diabetic patients are prone to 
various complications such as stroke, heart failure, acute myocardial infarction, nephropathy, 
and retinopathy [60] and [61]. Like diagnosed diabetic patients, the undiagnosed diabetic 
individuals are experiencing risk of coronary heart disease about twice that for non-diabetic 
individuals and significantly higher mortality rate, i.e. 23% as compared to 9% in non-
diabetic individuals [61]. 
Chinese populations are huge in and outside Mainland China. Within Mainland 
China, the population is estimated to reach 1.38 billion in the year 2023 [62]. Hence, increase 
in prevalence of diabetes will result in tremendous rise in healthcare costs in treatment, 
hospitalisations and management of complications associated with diabetes [63] and [64]. In 
Taiwan, healthcare cost for diabetic patients accounted for 13% of the National Health 
Insurance cost in 1999 [65]. As compared to non-diabetic patients, the diabetic patients 
incurred 3.5 times more inpatient costs due to their more frequent hospitalisation and longer 
hospital stay [66]. Impact of diabetes on healthcare cost was reflected in reports published in 
other countries as well. In Mexico, the average annual cost per diabetic patient was 708 
American dollars resulted in a 15.5% of the total health spending in a population with a 
prevalence rate of diabetes of 7.2% in 1993 [67]. In the United States of America, the 
healthcare cost of diabetes accounted for 14.6% of the total health spending (105 billion 
American dollars) with a prevalence rate of diabetes of 4.5% in 1992 [68]. Approximately 
half of the expenditures were for treatment of diabetes and half for treatment of the 
complications of diabetes [69]. Hence, the burden in healthcare costs will be greater if 
diabetes is undiagnosed and/or uncontrolled as complications will develop. 
Some limitations of this review are illustrated as follows. The percentages of 
undiagnosed diabetes were computed based on the limited numbers of studies that provided 
primary data on undiagnosed diabetes. In categorising age-ranges, a problem was faced with 
age-range such as 25–34 years because it somehow overlapped with 20–29 and 30–39 years 
age groups. Hence, pooling of age groups was applied, i.e. data for 25–34 years group was 
pooled into 30–39 years; 35–44 years group was pooled into 40–49 years, etc. This pooling 
method led to discrepancy in categorisation in five studies [15], [16], [17], [27] and [34], 
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which was assumed to be negligible in comparing the trends and differences of the prevalence 
rates. 
 
5. Conclusion 
 
Despite the limitations, this review provides consolidated information about the overall trends 
of prevalence of diabetes and IGT, and significance of undiagnosed diabetes of the Chinese 
populations in Mainland China, Hong Kong, and Taiwan. The findings may reflect some 
potential effects of urbanisation and lifestyle (such as lack of physical activity and high-fat 
diet) on prevalence of diabetes. This information is useful for public health planning and 
health promotion such as diabetes screening, management and education. 
Chinese people in Mainland China are currently experiencing an upward trend in the 
prevalence of diabetes. They have not reached the level of Chinese people living in developed 
regions. With economic advancement, change toward urbanised lifestyle (i.e. lack of physical 
activity and increase caloric intake), and the consequent increase in obesity; there will be 
potential increase in the prevalence of diabetes in the Chinese population. The high 
proportions of diabetic patients are undiagnosed should raise the awareness for intervention to 
curb the undesirable upward trend. If there are no early diagnosis and intervention strategies 
for diabetes and IGT, tremendous increase in burdens caused by diabetes will ensue.  
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